Oral Prolonged-Release Ketamine for Treatment-Resistant Depression: Two Randomized Clinical Trials.
Walter M +10 more
europepmc +1 more source
Esketamine Nasal Spray: Mechanism of Action, Clinical, and Translational Science. [PDF]
van Hoogdalem MW +3 more
europepmc +1 more source
Esketamine ameliorates depression-like behavior in mice via modulation of the NRG1-ErbB4 pathway. [PDF]
Yu H +11 more
europepmc +1 more source
Sustained effectiveness and safety of esketamine for major depressive disorder: a target trial simulation of real-world data. [PDF]
Liu TH +5 more
europepmc +1 more source
Repeated intranasal esketamine augmentation in treatment-resistant obsessive-compulsive disorder with comorbid major depressive disorder: a prospective case series. [PDF]
López-Rodríguez S +6 more
europepmc +1 more source
Cost-effectiveness of esketamine versus alternative treatment strategies for treatment-resistant depression in Hong Kong: A multi-armed modeling study. [PDF]
Li Y +9 more
europepmc +1 more source
Effects of Intravenous Esketamine or Magnesium Sulfate on Early Postoperative Negative Emotions and Pain in Patients Undergoing Endoscopic Sinus Surgery: A Randomized Controlled Trial. [PDF]
Wang L +5 more
europepmc +1 more source
Effects of Esketamine Infusion by Patient-Controlled Intravenous Analgesia in Patients With Zoster-Associated Pain: A Retrospective Study. [PDF]
Lou Y, Zhou S, Ying Y.
europepmc +1 more source
Median effective dose (ED<sub>50</sub>) of esketamine combined with different doses of propofol for children to inhibit the response to gastroscope insertion: a prospective dose-response clinical study. [PDF]
Niu K, Li L, Wu X, Xia N, Zhu J.
europepmc +1 more source
Efficacy and safety evaluation of intravenous esketamine in alleviating perioperative depressive symptoms in Parkinson's disease: a randomized controlled trial. [PDF]
Tan W, Gao Y, Su D, Ji L, Wang S.
europepmc +1 more source

